On the 28th of May 2020 CROS NT conducted a webinar focused on current trial designs that can help to decrease the risk of failure and reduce the costs, we have also discussed their advantages and disadvantages.
Webinar learning outcomes:
- Basics of adaptive designs
- How to evaluate the benefit of an adaptive design for biopharma
The webinar was presented by Thomas Zwingers, Statistical Consultant of CROS NT, has been working in the clinical trial environment since 1980. He is specialized in statistical analysis and reporting with particular expertise in Adaptive Trial Design.
Prior to joining CROS NT, Thomas ran his own biometrics consulting CRO in Germany for over 20 years. During this time, he gained a considerable amount of experience in Dermatology, Respiratory and Oncology studies.
Thomas holds a Master’s degree in Cybernetics from the Technical University of Munich. He is member of numerous international associations, including the Biometric Society, International Society for Clinical Biostatistics and the Society for Clinical Trials. He has written and collaborated on over 100 publications in the pharmaceutical and clinical trial statistics.
Thomas provides pharmaceutical, biotech and medical device companies with statistical methodology advice pertaining to trial design, conduct and reporting including regulatory submission. He has presented statistical findings to the European Medicines Agency and other regulatory authorities on numerous occasions.